featured
RCT of Anti–interleukin-21 for β-Cell Function in Adult, Recent-Onset Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti–Interleukin-21 Antibody and Liraglutide for the Preservation of β-Cell Function in Adults With Recent-Onset Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Lancet Diabetes Endocrinol 2021 Mar 01;[EPub Ahead of Print], M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, J Gumprecht, TK Hansen, C Mathieu, C Morales, O Mosenzon, S Segel, G Tsoukas, TR PieberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.